Literature DB >> 18003487

Current developments in tissue engineering of nucleus pulposus for the treatment of intervertebral disc degeneration.

Immanuel M Sebastine1, David J Williams.   

Abstract

The main cause for back pain is considered to be the degenerative changes in the intervertebral disc (IVD). Some evidence indicates that IVD degeneration originates from the nucleus pulposus (NP). The IVD does not possess self repair capacity. Current treatment options range from pain management to invasive procedures. The science of disc cell transplantation is still in its infancy. Advancement in bioengineering based upon tissue engineering techniques may offer the possibility of repairing damaged disc, if an engineered NP with the appropriate functional properties can be generated to augment the degenerated disc. This is likely to require triaxial stimulation of tissue engineering constructs.

Entities:  

Mesh:

Year:  2007        PMID: 18003487     DOI: 10.1109/IEMBS.2007.4353821

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  16 in total

1.  In vitro and in silico investigations of disc nucleus replacement.

Authors:  Sandra Reitmaier; Aboulfazl Shirazi-Adl; Maxim Bashkuev; Hans-Joachim Wilke; Antonio Gloria; Hendrik Schmidt
Journal:  J R Soc Interface       Date:  2012-02-15       Impact factor: 4.118

Review 2.  Scaffolding in tissue engineering: general approaches and tissue-specific considerations.

Authors:  B P Chan; K W Leong
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

3.  Methods to monitor distribution and metabolic activity of mesenchymal stem cells following in vivo injection into nucleotomized porcine intervertebral discs.

Authors:  G W Omlor; H Bertram; K Kleinschmidt; J Fischer; K Brohm; T Guehring; M Anton; Wiltrud Richter
Journal:  Eur Spine J       Date:  2009-12-29       Impact factor: 3.134

4.  Intervertebral disk tissue engineering using biphasic silk composite scaffolds.

Authors:  Sang-Hyug Park; Eun Seok Gil; Hongsik Cho; Biman B Mandal; Lee W Tien; Byoung-Hyun Min; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2011-10-26       Impact factor: 3.845

5.  Development of a KLD-12 polypeptide/TGF-β1-tissue scaffold promoting the differentiation of mesenchymal stem cell into nucleus pulposus-like cells for treatment of intervertebral disc degeneration.

Authors:  Zhengjun Bian; Jianhua Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

6.  Experimental study on self-assembly of KLD-12 peptide hydrogel and 3-D culture of MSC encapsulated within hydrogel in vitro.

Authors:  Jianhua Sun; Qixin Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

7.  Biocompatibility of KLD-12 peptide hydrogel as a scaffold in tissue engineering of intervertebral discs in rabbits.

Authors:  Jianhua Sun; Qixin Zheng; Yongchao Wu; Yudong Liu; Xiaodong Guo; Weigang Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-04-21

8.  Genipin-crosslinked fibrin hydrogels as a potential adhesive to augment intervertebral disc annulus repair.

Authors:  R M Schek; A J Michalek; J C Iatridis
Journal:  Eur Cell Mater       Date:  2011-04-18       Impact factor: 3.942

Review 9.  Recent advances in annular pathobiology provide insights into rim-lesion mediated intervertebral disc degeneration and potential new approaches to annular repair strategies.

Authors:  James Melrose; Susan M Smith; Christopher B Little; Robert J Moore; Barrie Vernon-Roberts; Robert D Fraser
Journal:  Eur Spine J       Date:  2008-06-27       Impact factor: 3.134

Review 10.  Biologic treatment of mild and moderate intervertebral disc degeneration.

Authors:  Elias S Vasiliadis; Spyros G Pneumaticos; Demitrios S Evangelopoulos; Athanasios G Papavassiliou
Journal:  Mol Med       Date:  2014-09-18       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.